Atreides Management’s Confluent CFLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,012,215
Closed -$75.1M 59
2025
Q2
$75.1M Buy
3,012,215
+1,357,246
+82% +$30.6M 2.08% 20
2025
Q1
$38.8M Buy
1,654,969
+104,718
+7% +$3.03M 1.18% 25
2024
Q4
$43.3M Sell
1,550,251
-1,156,659
-43% -$31M 0.95% 25
2024
Q3
$55.2M Buy
2,706,910
+184,865
+7% +$4.14M 1.4% 24
2024
Q2
$74.5M Buy
2,522,045
+489,776
+24% +$14.1M 2.43% 18
2024
Q1
$62M Buy
2,032,269
+5,496
+0.3% +$155K 1.41% 21
2023
Q4
$47.4M Sell
2,026,773
-986,579
-33% -$23.8M 1.56% 26
2023
Q3
$89.2M Sell
3,013,352
-993,791
-25% -$33.3M 2.92% 13
2023
Q2
$141M Buy
4,007,143
+176,338
+5% +$4.93M 3.63% 9
2023
Q1
$92.2M Buy
+3,830,805
New +$88.8M 2.82% 15
2022
Q4
Sell
-177,894
Closed -$4.23M 37
2022
Q3
$4.23M Sell
177,894
-1,699,897
-91% -$45.8M 0.11% 38
2022
Q2
$43.6M Buy
+1,877,791
New +$50.5M 1.62% 24

Other funds holding CFLT

Atreides Management's CFLT Position: Q3 2025 in Review

Atreides Management sold out of Confluent (CFLT) in Q3 2025, closing a stake of 3,012,215 shares — an estimated $75.1M sold.

Atreides Management first reported a position in CFLT in Q2 2022 and held it in 12 quarters. The position peaked at $141M in Q2 2023. 385 funds tracked by Wall St. Rank hold CFLT as of Q3 2025.

  • Atreides Management reported no remaining Confluent position as of Q3 2025 after selling out during the quarter.
  • Atreides Management sold 3,012,215 Confluent shares in Q3 2025, an estimated $75.1M.
  • Atreides Management first reported a position in Confluent in Q2 2022 and held it in 12 quarters.
  • Atreides Management's Confluent position peaked at $141M in Q2 2023.
  • 385 funds tracked by Wall St. Rank held Confluent as of Q3 2025.

Based on Atreides Management's 13F filing for Q3 2025, filed 14 Nov 2025.